Biomarkers of cerebrovascular disease in dementia

British Journal of Radiology

Volumn 80, Issue SPEC. ISS. 2, 2007, Pages

  Mills, S ^a   Cain, J ^a   Purandare, N ^a   Jackson, Alan ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; NIMODIPINE;

AGING; ALZHEIMER DISEASE; BRAIN EMBOLISM; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; HOMEOSTASIS; HUMAN; HYPERTENSION; LEUKOARAIOSIS; MICROANGIOPATHY; MIXED DEPRESSION AND DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; BRAIN DISEASE; BRAIN VENTRICLE PERITONEUM SHUNT; DEGENERATIVE DISEASE; DISEASE COURSE; NEUROIMAGING; RISK FACTOR; VASCULAR DISEASE; WHITE MATTER; COGNITIVE DEFECT; MULTIINFARCT DEMENTIA; PSYCHOLOGICAL ASPECT;

ALZHEIMER DISEASE; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DEMENTIA; DEMENTIA, VASCULAR; HUMANS; HYPOTENSION, ORTHOSTATIC; INTRACRANIAL EMBOLISM; MAGNETIC RESONANCE IMAGING;

EID: 43549094239     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/79217686     Document Type: Review

References (198)

1. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998;51:159-62.
2. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-7.
3. Kalaria R. Similarities between Alzheimer's disease and vascular dementia. J Neurol Sci 2002;203-204:29-34.
4. Kalaria RN. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann NY Acad Sci 1999;893:113-25.
5. Kalaria RN. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 2002;13 (Suppl 2)48-52.
6. Kalaria RN. Vascular factors in Alzheimer's disease. Int Psychogeriatr 2003;15 (Suppl 1):47-52.
7. Kalback W, Esh C, Castano EM, Rahman A, Kokjohn T, Luehrs DC, et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 2004;26:525-39.
8. Hachinski V, Munoz DG. Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon? Ann NY Acad Sci 1997;826:1-6.
9. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NPNDS-AIREN International Workshop. Neurology 1993;43:250-60.
10. Rocca WA, Amaducci LA, Schoenberg BS. Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 1986;19:415-24.
11. Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-8.
12. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 1994;154:2154-60.
13. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51.
14. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002;162:2046-52.
15. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003;21:875-86.
16. Prince MJ. Predicting the onset of Alzheimer's disease using Bayes' theorem. Am J Epidemiol 1996;143:301-8.
17. Skoog I, Lithell H, Hansson L, Elmfeldt D, Hofman A, Olofsson B, et al. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on Cognition and Prognosis in the Elderly (SCOPE). Am J Hypertens 2005;18:1052-9.
18. Tzourio C. Vascular factors and cognition: toward a prevention of dementia? J Hypertens Suppl 2003;21:S15-9.
19. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. Effects of blood pressure lowering with perindopril and Indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-75.
20. Ban TA, Morey L, Aguglia E, Azzarelli O, Balsano F, Marigliano V, et al. Nimodipine in the treatment of old age dementias. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:525-51.
21. Silverberg GD, Levinthal E, Sullivan EV, Bloch DA, Chang SD, Leverenz J, et al. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 2002;59:1139-45.
22. de la Torre JC. Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology 1997;43:26-43.
23. Zekry D, Duyckaerts C, Belmin J, Geoffre C, Moulias R, Hauw JJ. Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology. J Neurol 2002;249:1529-34.
24. Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, et al. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl) 2002;103:481-7.
25. Buee L, Hof PR, Delacourte A. Brain microvascular changes in Alzheimer's disease and other dementias. Ann N Y Acad Sci 1997;826:7-24.
26. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000;21:321-30.
27. Kudo T, Imaizumi K, Tanimukai H, Katayama T, Sato N, Nakamura Y, et al. Are cerebrovascular factors involved in Alzheimer's disease? Neurobiol Aging 2000;21:215-24.
28. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152-62.
29. de la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann NY Acad Sci 2002;977:196-215.
30. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease? Ann NY Acad Sci 2000;903:424-36.
31. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging 2000;21:331-42.
32. Korczyn AD. The underdiagnosis of the vascular contribution to dementia. J Neurol Sci 2005;229-230:3-6.
33. Kotila M. Four-year prognosis of patients under the age of 65 surviving their first ischaemic brain infarction. Ann Clin Res 1986;18:76-9.
34. Kotila M, Waltimo O, Niemi ML, Laaksonen R. Dementia after stroke. Eur Neurol 1986;25:134-40.
35. Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42:1185-93.
36. Tatemichi TK, Desmond DW, Stern Y, Paik M, Sano M, Bagiella E. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994;57:202-7.
37. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Pirro M, Hanzawa LK. Dementia after stroke is a predictor of long-term survival. Stroke 1994;25:1915-9.
38. Ironside JW. Central and peripheral nervous systems. 1 edition. New York: Churchill Livingstone; 1992.
39. Zimmerman RD, Fleming CA, Lee BC, Saint-Louis LA, Deck MD. Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJR Am J Roentgenol 1986;146:443-50.
40. Tian J, Shi J, Bailey K, Mann DM. Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease. Neuropathol Appl Neurobiol 2004;30:46-56.
41. Fazekas F, Alavi A, Chawluk JB, Zimmerman RA, Hackney D, Bilaniuk L, et al. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. J Nucl Med 1989;30:1607-15.
42. Yamaji S, Ishii K, Sasaki M, Imamura T, Kitagaki H, Sakamoto S, et al. Changes in cerebral blood flow and oxygen metabolism related to magnetic resonance imaging white matter hyperintensities in Alzheimer's disease. J Nucl Med 1997;38:1471-4.
43. Takahashi W, Takagi S, Ide M, Shohtsu A, Shinohara Y. Reduced cerebral glucose metabolism in subjects with incidental hyperintensities on magnetic resonance imaging. J Neurol Sci 2000;176:21-7.
44. Purandare N, Oude Voshaar RC, Davidson Y, Gibbons L, Hardicre J, Byrne J, et al. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: a pilot study. J Am Geriatr Soc 2006;54:1395-400.
45. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683-9.
46. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149: 351-6.
47. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7-12.
48. Fazekas F, Barkhof F, Wahlund LO, Pantoni L, Erkinjuntti T, Scheltens P, et al. CT and MRI rating of white matter lesions. Cerebrovasc Dis 2002;13 Suppl 2:31-6.
49. Scheltens P, Erkinjunti T, Leys D, Wahlund LO, Inzitari D, del Ser T, et al. White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998;39:80-9.
50. Bowen BC, Barker WW, Loewenstein DA, Sheldon J, Duara R. MR signal abnormalities in memory disorder and dementia. AJR Am J Roentgenol 1990;154:1285-92.
51. Kertesz A, Polk M, Carr T. Cognition and white matter changes on magnetic resonance imaging in dementia. Arch Neurol 1990;47:387-91.
52. Mirsen TR, Lee DH, Wong CJ, Diaz JF, Fox AJ, Hachinski V, et al. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 1991;48:1015-21.
53. Schmidt R. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992;32:164-9.
54. Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992;115:735-48.
55. Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995;45:883-8.
56. Fazekas F, Kapeller P, Schmidt R, Offenbacher H, Payer F, Fazekas G. The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease. J Neurol Sci 1996;142:121-5.
57. Tanabe JL, Amend DL, Schuff N, DiSclafani V, Ezekiel F, Norman D, et al. Tissue segmentation of the brain in Alzheimer disease. AJNR Am J Neuroradiol 1997;18:115-23.
58. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72.
59. Fernaeus SE, Almkvist O, Bronge L, Ostberg P, Hellstrom A, Winblad B, et al. White matter lesions impair initiation of FAS flow. Dement Geriatr Cogn Disord 2001;12:52-6.
60. Bigler ED, Kerr B, Victoroff J, Tate DF, Breitner JC. White matter lesions, quantitative magnetic resonance imaging, and dementia. Alzheimer Dis Assoc Disord 2002;16:161-70.
61. Swartz RH, Black SE, Feinstein A, Rockel C, Sela G, Gao FQ, et al. Utility of simultaneous brain, CSF and hyperintensity quantification in dementia. Psychiatry Res 2002;116:83-93.
62. Petkov CI, Wu CC, Eberling JL, Mungas D, Zrelak PA, Yonelinas AP, et al. Correlates of memory function in community-dwelling elderly: the importance of white matter hyperintensities. J Int Neuropsychol Soc 2004;10: 371-81.
63. Kenny RA, Shaw FE, O'Brien JT, Scheltens P, Kalaria R, Ballard C. Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions. J Neurol Neurosurg Psychiatry 2004;75:966-71.
64. Kono I, Mori S, Nakajima K, Nakagawa M, Watanabe Y, Kizu O, et al. Do white matter changes have clinical significance in Alzheimer's disease? Gerontology 2004;50: 242-6.
65. van der Flier WM, Middelkoop HAM, Weverling-Rijnsburger AWE, Admiraal-Behloul F, Bollen ELEM, Westendorp RGJ, et al. Neuropsychological correlates of MRI measures in the continuum of cognitive decline. Dement Geriatr Cogn Disord 2005;20:82-8.
66. Nordahl CW, Ranganath C, Yonelinas AP, DeCarli C, Reed B, Jagust WJ. Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia. 2005;43:1688-97.
67. Patankar TF, Mitra D, Varma A, Snowden J, Neary D, Jackson A. Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia. AJNR Am J Neuroradiol 2005;26:1512-20.
68. Burton EJ, McKeith IG, Burn DJ, Firbank M, O'Brien JT. Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia; a comparison with normal aging. Am J Geriatr Psychiatry 2006;14:842-9.
69. Yoshita M, Fletcher E, Harvey D, Ortega M, Martinez O, Mungas D, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006;67:2192-8.
70. Wahlund LO, Basun H, Almkvist O, Andersson-Lundman G, Julin P, Saaf J. White matter hyperintensities in dementia: does it matter? Magn Reson Imaging 1994;12: 387-94.
71. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith I, Morris CM, et al. Apoliprotein E epsilon 4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Arch Neurol 1999;56:961-5.
72. 2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias. Acta Neurol Scand 2002;105:355-64.
73. Ferro JM, Madureira S. Age-related white matter changes and cognitive impairment. J Neurol Sci 2002;203:221-5.
74. Purandare N, Burns A, Daly KJ, Hardicre J, Morris J, Macfarlane G, et al. Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study. Br Med J 2006;332:1119-24.
75. Beyer MK, Aarsland D, Greve OJ, Larsen JP. Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord. 2006;21:223-9.
76. Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol 1990;11:273-81.
77. Leys D, Soetaert G, Petit H, Fauquette A, Pruvo JP, Steinling M. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol 1990;47:524-527.
78. Kozachuk WE, DeCarli C, Schapiro MB, Wagner EE, Rapoport SI, Horwitz B. White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. Arch Neurol 1990;47:1306-10.
79. McDonald WM, Krishnan KR, Doraiswamy PM, Figiel GS, Husain MM, Boyko OB, et al. Magnetic resonance findings in patients with early-onset Alzheimer's disease. Biol Psychiatry 1991;29:799-810.
80. Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC. Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol 1994;51:260-8.
81. Doddy RS, Massman PJ, Mawad M, Nacne M. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischaemic vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol. 1998;11:191-9.
82. Smith CD, Snowdon DA, Wang H, Markesbery WR. White matter volumes and periventricular white matter hyperintensities in aging and dementia. Neurology 2000;54: 838-42.
83. Junque C, Pujol J, Vendrell P, Bruna O, Jodar M, Ribas JC, et al. Leukoaraiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 1990;47:151-6.
84. Burton EJ, Kenny RA, O'Brien J, Stephens S, Bradbury M, Rowan E, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 2004;35:1270-5.
85. Jokinen H, Kalska H, Mantyla R, Ylikoski R, Hietanen M, Pohjasvaara T, et al. White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry 2005;76:1229-33.
86. van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 2005;36:2116-20.
87. Soderlund H, Nilsson LG, Berger K, Breteler MM, Dufouil C, Fuhrer R, et al. Cerebral changes on MRI and cognitive function: the CASCADE study. Neurobiol Aging 2006;27: 16-23.
88. Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006;22:376-84.
89. Rossi R, Geroldi C, Bresciani L, Testa C, Binetti G, Zanetti O, et al. Clinical and neuropsychological features associated with structural imaging patterns in patients with mild cognitive impairment. Dement Geriatr Cogn Disord 2007;23:175-83.
90. Grau-Olivares M, Bartres-Faz D, Arboix A, Soliva JC, Rovira M, Targa C, et al. Mild cognitive impairment after lacunar infarction: voxel based morphometry and neuropsychological assessment. Cerebrovasc Dis 2007;23:353-61.
91. Rao SM, Mittenberg W, Bernardin L, Haughton V, Leo GJ. Neuropsychological test findings in subjects with leukoaraiosis. Arch Neurol 1989;46:40-4.
92. Yamashita K, Kobayashi S, Fukuda H, Yamaguchi S, Koide H. Leukoaraiosis and event-related potentials (P300) in normal aged subjects. Gerontology 1992;38:233-40.
93. Jorm AF, Butterworth P, Anstey KJ, Christensen H, Easteal S, Maller J, et al. Memory complaints in a community sample aged 60-64 years: associations with cognitive functioning, psychiatric symptoms, medical conditions, APOE genotype, hippocampus and amygdala volumes, and white-matter hyperintensities. Psychol Med 2004;34: 1495-506.
94. Kumar R, Parslow RA, Jorm AF, Rosenman SJ, Maller J, Meslin C, et al. Clinical and neuroimaging correlates of mild cognitive impairment in a middle-aged community sample: the personality and total health through life 60+ study. Dement Geriatr Cogn Disord 2006;21:44-50.
95. Firbank M, Burton EJ, Barber R, Stephens S, Kenny RA, Ballard C, et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging 2007;28:1664-9.
96. Rabbitt P, Scott M, Lunn M, Thacker N, Lowe C, Pendleton N, et al. White matter lesions account for all age-related declines in speed but not in intelligence. Neuropsychology 2007;21:363-70.
97. Rabbitt P, Scott M, Thacker N, Lowe C, Jackson A, Horan M, et al. Losses in gross brain volume and cerebral blood flow account for age-related differences in speed but not in fluid intelligence..Neuropsychology 2006;20:549-57.
98. van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, Olofsen H, Bollen EL, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry 2006;77:149-53.
99. Meyer JS, Rauch G, Rauch RA, Haque A. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging 2000;21:161-9.
100. Meyer JS, Rauch GM, Crawford K, Rauch RA, Konno S, Akiyama H, et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry 1999;14:1050-61.
101. Garde E, Lykke Mortensen E, Rostrup E, Paulson OB. Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 2005;76:1289-91.
102. Garde E, Mortensen EL, Krabbe K, Rostrup E, Larsson HB. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 2000;356:628-34.
103. Leaper SA, Murray AD, Lemmon HA, Staff RT, Deary IJ, Crawford JR, et al. Neuropsychologic correlates of brain white matter lesions depicted on MR images: 1921 Aberdeen Birth Cohort. Radiology 2001;221:51-5.
104. De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-41.
105. Schmidt R, Schmidt H, Kapeller P, Lechner A, Fazekas F. Evolution of white matter lesions. Cerebrovasc Dis 2002;13 Suppl 2:16-20.
106. DeCarli C, Mungas D, Harvey D, Reed B, Weiner M, Chui H, et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 2004;63:220-7.
107. Baldwin RC. Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. Int J Geriatr Psychiatry 2005;20:1-11.
108. Jellinger KA. The pathology of ischemic-vascular dementia: an update. J Neurol Sci 2002;203-204:153-7.
109. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997;63:749-53.
110. Hommel M, Gray F. Microvascular pathology. New York: Springer; 1995.
111. Poirier J, Derouesne C. Cerebral lacunae. A proposed new classification. Clin Neuropathol 1984;3:266.
112. Baldwin RC, O'Brien J. Vascular basis of late-onset depressive disorder. Br J Psychiatry 2002;180:157-60.
113. Hulette C ND, McKeel D, Morris K, Mirras SS, Sumi SM, et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology 1997;48:668-72.
114. O'Brien JT, Ames D. White matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996;169:671.
115. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. "Vascular depression" hypothesis. Arch Gen Psychiatry 1997;54:915-22.
116. Tiemeier H, Bakker SL, Hofman A, Koudstaal PJ, Breteler MM. Cerebral haemodynamics and depression in the elderly. J Neurol Neurosurg Psychiatry 2002;73:34-9.
117. Thomas AJ, O'Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 2002;59:785-92.
118. Baldwin RC, Walker S, Simpson SW, Jackson A, Burns A. The prognostic significance of abnormalities seen on magnetic resonance imaging in late life depression: clinical outcome, mortality and progression to dementia at three years. Int J Geriatr Psychiatry 2000;15:1097-104.
119. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin MP, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995;37:151-60.
120. O'Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. Br Med J 1998;317:982-4.
121. Simpson S, Baldwin RC, Jackson A, Burns AS. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 1998;28:1015-26.
122. Thomas AJ, Perry R, Barber R, Kalaria RN, O'Brien JT. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann NY Acad Sci 2002;977:333-9.
123. Thomas AJ, Perry R, Kalaria RN, Oakley A, McMeekin W, O'Brien JT. Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry 2003;18:7-13.
124. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997;154:497-501.
125. Krishnan KR, McDonald WM. Arteriosclerotic depression. Med Hypotheses 1995;44:111-5.
126. Greenwald BS, Kramer-Ginsberg E, Krishnan KR, Hu J, Ashtari M, Wu H, et al. A controlled study of MRI signal hyperintensities in older depressed patients with and without hypertension. J Am Geriatr Soc 2001;49:1218-25.
127. Thacker NA, Varma AR, Bathgate D, Stivaros S, Snowden JS, Neary D, et al. Dementing disorders: volumetric measurement of cerebrospinal fluid to distinguish normal from pathologic findings - feasibility study. Radiology 2002;224:278-85.
128. Patankar TF, Baldwin R, Mitra D, Jeffries S, Sutcliffe C, Burns A, et al. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. J Affect Disord 2007;97:265-70.
129. Naish JH, Baldwin RC, Patankar T, Jeffries S, Burns AS, Taylor CJ, et al. Abnormalities of CSF flow patterns in the cerebral aqueduct in treatment-resistant late-life depression: a potential biomarker of microvascular angiopathy. Magn Reson Med 2006;56:509-16.
130. Derouesne C, Poirier J. Cerebral lacunae: still under debate. Rev Neurol (Paris) 1999;155:823-31.
131. Varma AR, Adams W, Lloyd JJ, Carson KJ, Snowden JS, Testa HJ, et al. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, fronto-temporal dementia and vascular dementia. Acta Neurol Scand 2002;105:261-9.
132. Loeb C. Dementia due to lacunar infarctions: a misnomer or a clinical entity? Eur Neurol 1995;35:187-92.
133. Viswanathan A, Gschwendtner A, Guichard JP, Buffon F, Cumurciuc R, O'Sullivan M, et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology 2007;69:172-9.
134. Cordonnier C, van der Flier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006;66:1356-60.
135. Meyer JS, Quach M, Thornby J, Chowdhury M, Huang J. MRI identifies MCI subtypes: vascular versus neurodegenerative. J Neurol Sci 2005;229-230:121-9.
136. 2*-weighted magnetic resonance imaging study. Neurosci Lett 2003;340:213-6.
137. Baldwin R, Jeffries S, Jackson A, Sutcliffe C, Thacker N, Scott M, et al. Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors. Psychol Med 2004;34:125-36.
138. Baldwin R, Jeffries S, Jackson A, Sutcliffe C, Thacker N, Scott M, et al. Neurological findings in late-onset depressive disorder: comparison of individuals with and without depression. Br J Psychiatry 2005;186:308-13.
139. Simpson S, Baldwin RC, Jackson A, Burns A, Thomas P. Is the clinical expression of late-life depression influenced by brain changes? MRI subcortical neuroanatomical correlates of depressive symptoms. Int Psychogeriatr 2000;12: 425-34.
140. Baldwin RC, Walker S, Jackson A, Simpson SW, Burns A. Severe deep white matter lesions and outcome in major depressive disorder. Further investigation of deep white matter lesions is necessary. Br Med J 1999;318:738.
141. Heier LA, Bauer CJ, Schwartz L, Zimmerman RD, Morgello S, Deck MD. Large Virchow-Robin spaces: MR-clinical correlation. AJNR Am J Neuroradiol 1989;10:929-36.
142. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. AJR Am J Roentgenol 1988;151:551-8.
143. Machado MA, Jr., Matos AS, Goyanna F, Barbosa VA, Vieira LC. Dilatation of Virchow-Robin spaces in patients with migraine. Arq Neuropsiquiatr 2001;59:206-9.
144. 2-weighted MR images: Virchow-Robin spaces of the extreme capsule and insular cortex. Radiology 2000;214: 671-7.
145. Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol 1998;245:116-22.
146. Fazekas F, Kleinert R, Offenbacher H, Payer F, Schmidt R, Kleinert G, et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 1991,12:915-21.
147. Ogawa T, Okudera T, Fukasawa H, Hashimoto M, Inugami A, Fujita H, et al. Unusual widening of Virchow-Robin spaces: MR appearance. AJNR Am J Neuroradiol 1995;16:1238-42.
148. Hughes W. Origin of lacunes. Lancet. 1965;1:19-21.
149. Benhaiem-Sigaux N, Gray F, Gherardi R, Roucayrol AM, Poirier J. Expanding cerebellar lacunes due to dilatation of the perivascular space associated with Binswanger's subcortical arteriosclerotic encephalopathy. Stroke 1987;18:1087-92.
150. Derouesne C, Gray F, Escourolle R, Castaigne P. "Expanding cerebral lacunae" in a hypertensive patient with normal pressure hydrocephalus. Neuropathol Appl Neurobiol 1987;13:309-20.
151. Pullicino PM, Miller LL, Alexandrov AV, Ostrow PT. Infraputaminal "lacunes". Clinical and pathological correlations. Stroke 1995;26:1598-602.
152. Duprez DA, De Buyzere ML, Van den Noortgate N, Simoens J, Achten E, Clement DL, et al. Relationship between periventricular or deep white matter lesions and arterial elasticity indices in very old people. Age Ageing 2001;30:325-30.
153. Rigaud AS, Seux ML, Staessen JA, Birkenhager WH, Forette F. Cerebral complications of hypertension. J Hum Hypertens 2000;14:605-16.
154. Celis H, Fagard RH, Staessen JA, Thijs L. Risk and benefit of treatment of isolated systolic hypertension in the elderly: evidence from the Systolic Hypertension in Europe Trial. Curr Opin Cardiol 2001;16:342-8.
155. Fogari R, Mugellini A, Zoppi A, Marasi G, Pasotti C, Poletti L, et al. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur J Clin Pharmacol 2004;59:863-8.
156. Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of "vascular depression". Int J Geriatr Psychiatry 2001;16:254-60.
157. De Leeuw FE, Barkhof F, Scheltens P. Alzheimer's disease - one clinical syndrome, two radiological expressions: a study on blood pressure. J Neurol Neurosurg Psychiatry 2004;75:1270-4.
158. McEniery CM, Yasmin, Wallace S, Maki-Petaja K, McDonnell B, Sharman JE, et al. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension 2005;46:221-6.
159. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006;113:657-63.
160. Scuteri A, Brancati AM, Gianni W, Assisi A, Volpe M. Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: a pilot study. J Hypertens 2005;23:1211-6.
161. Bateman GA. Pulse-wave encephalopathy: a comparative study of the hydrodynamics of leukoaraiosis and normal-pressure hydrocephalus. Neuroradiology 2002;44:740-8.
162. Greitz D. The hydrodynamic hypothesis versus the bulk flow hypothesis. Neurosurg Rev 2004;27:299-300.
163. Stolz E, Kaps M, Kern A, Babacan SS, Dorndorf W. Transcranial color-coded duplex sonography of intracranial veins and sinuses in adults. Reference data from 130 volunteers. Stroke 1999;30:1070-5.
164. Greitz DG, T. The pathogenesis and hemodynamics of hydrocephalus. A proposal for a new understanding. Int J Neuroradiol 1997;3:367-375.
165. Stivaros SM, Jackson A. Changing concepts of cerebrospinal fluid hydrodynamics: role of phase-contrast magnetic resonance imaging and implications for cerebral microvascular disease. Neurotherapeutics 2007;4:511-22.
166. Greitz D. Radiological assessment of hydrocephalus: new theories and implications for therapy. Neurosurg Rev 2004;27:145-65, discussion 166-7
167. Bateman GA. Vascular compliance in normal pressure hydrocephalus. AJNR Am J Neuroradiol 2000;21:1574-85.
168. Bateman GA. The reversibility of reduced cortical vein compliance in normal-pressure hydrocephalus following shunt insertion. Neuroradiology 2003;45:65-70.
169. Bateman GA. Vascular hydraulics associated with idiopathic and secondary intracranial hypertension. AJNR Am J Neuroradiol 2002;23:1180-6.
170. Mathew NT, Meyer JS, Ott EO. Increased cerebral blood volume in benign intracranial hypertension. Neurology 1975;25:646-9.
171. Bateman GA. The role of altered impedance in the pathophysiology of normal pressure hydrocephalus, Alzheimer's disease and syringomyelia. Med Hypotheses 2004;63:980-5.
172. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61:1531-4.
173. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-9.
174. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-52.
175. Altaf N, Daniels L, Morgan PS, Lowe J, Gladman J, MacSweeney ST, et al. Cerebral white matter hyperintense lesions are associated with unstable carotid plaques. Eur J Vasc Endovasc Surg 2006;31:8-13.
176. Russell D. Cerebral microemboli and cognitive impair-ment. J Neurol Sci 2002;203-204:211-4.
177. Hutchinson S, Riding G, Coull S, McCollum CN. Are spontaneous cerebral microemboli consistent in carotid disease? Stroke 2002;33:685-8.
178. Purandare N, Welsh S, Hutchinson S, Riding G, Burns A, McCollum C. Cerebral emboli and paradoxical embolisation in dementia: a pilot study. Int J Geriatr Psychiatry 2005;20:12-6.
179. Purandare N, Oude Voshaar RC, Burns A, Velupandian UM, McCollum C. Paradoxical embolization: a potential cause of cerebral damage in Alzheimer's disease? Neurol Res 2006;28:679-84.
180. Beelke M, Angeli S, Del Sette M, Gandolfo C, Cabano ME, Canovaro P, et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med 2003;4:219-23.
181. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998;8:327-30.
182. Finocchi C, Del Sette M, Angeli S, Rizzi D, Gandolfo C. Cluster headache and right-to-left shunt on contrast transcranial Doppler: a case-control study. Neurology 2004;63:1309-10.
183. Knauth M, Ries S, Pohimann S, Kerby T, Forsting M, Daffertshofer M, et al. Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. Br Med J 1997;314:701-5.
184. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-2.
185. Purandare N, Oude Voshaar R, McCollum C, Jackson A, Burns A. Paradoxical embolization and cerebral white matter lesions in dementia. Br J Radiol 2008;81:30-4.
186. Warkentin S, Passant U, Minthon L, Karlson S, Edvinsson L, Faldt R, et al. Redistribution of blood flow in the cerebral cortex of normal subjects during head-up postural change. Clin Auton Res 1992;2:119-24.
187. Passant U, Warkentin S, Gustafson L. Orthostatic hypotension and low blood pressure in organic dementia: a study of prevalence and related clinical characteristics. Int J Geriatr Psychiatry 1997;12:395-403.
188. Passant U, Warkentin S, Karlson S, Nilsson K, Edvinsson L, Gustafson L. Orthostatic hypotension in organic dementia: relationship between blood pressure, cortical blood flow and symptoms. Clin Auton Res 1996;6:29-36.
189. Risberg J, Passant U, Warkentin S, Gustafson L. Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer type. Dementia 1993;4:186-7.
190. Passant U, Warkentin S, Minthon L, Faldt R, Edvinsson L. Cortical blood flow during head-up postural change in subjects with orthostatic hypotension. Clin Auton Res 1993;3:311-8.
191. Kim J, Thacker N, Bromiley P, Beatty P. An electrical equivalence model for CSF pulsatility. In: Kozumplik J, Provazik J, editors. Proc. 17th Biennial International EURASIP Conference Biosignal 2004. Brno, Czech Republic: Vitium Press; 2004: 431-433.
192. Charletta D, Gorelick PB, Dollear TJ, Freels S, Harris Y. CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia. Neurology 1995;45:1456-61.
193. Sandson TA, Felician O, Edelman RR, Warach S. Diffusion-weighted magnetic resonance imaging in Alzheimer's disease. Dement Geriatr Cogn Disord 1999;10:166-71.
194. Tanabe JL, Ezekiel F, Jaqust WJ, Reed BR, Norman D, Schuff N, et al. Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. AJNR Am J Neuroradiol 1999;20:839-44.
195. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Werner MW, Jagust WJ, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626-35.
196. Hsu YY, Schuff N, Amend DL, Du AT, Norman D, Chui HC, et al. Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes. Alzheimer Dis Assoc Disord 2002;16:58-64.
197. Du AT, Schuff N, Laakso MP, Zhu XP, Jagust WJ, Yaffe K, et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002;58:1635-41.
198. van der Flier WM, Middelkoop HAM, Weverling-Rijnsburger AWE, Admiraal-Behloul F, Spilt A, Bollen ELEM, et al. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology 2004;62:1862-4.